SCGB3A1 and cancer: From the seven most promising candidates, six (APC, CCND2, FOXA1, PSAT1, RASSF1A and SCGB3A1) confirmed its cancer-specificity, discriminating normal from cancerous tissues, although with variable performance, paralleling previous observations from our team and others [8,9,38].